Users Online: 2119 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size
 

 

Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
     
BRIEF RESEARCH ARTICLE
Year : 2020  |  Volume : 64  |  Issue : 4  |  Page : 409-412

Cost of treatment and consequences for chronic hepatitis B and C virus infection at a tertiary care hospital in Delhi


1 Senior Resident, Government Medical College, Chandigarh, India
2 Professor and Head, Department of Planning and Evaluation, The National Institute of Health and Family Welfare, New Delhi, India
3 Assistant Research Officer, Department of Statistics and Demography, The National Institute of Health and Family Welfare, New Delhi, India

Correspondence Address:
Vijay Kumar Tiwari
Prof. and Head, Department of Planning and Evaluation, Dean of Studies, The National Institute of Health and Family Welfare, Munirka, New Delhi - 110 067
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/ijph.IJPH_356_19

Rights and Permissions

Patient living with chronic viral hepatitis in India faces the high cost of treatment and impoverishment. The present study is aimed to assess the cost of treatment and economic consequences among chronically infected viral hepatitis patients at a tertiary care hospital in Delhi. The descriptive cross-sectional study was undertaken during October 2016–January 2017. Three hundred and eighty-nine participants were interviewed through a schedule for variables and assessing both direct and indirect costs. Costs of hospital expenditure were extracted from records available with patients or databases of the hospital. The average outpatient expenditure and the inpatient costs were calculated. Direct nonmedical costs were also included. The analysis revealed the total cost of treatment ranged from Rs. 16,600/-to Rs. 1,709,000/-with a median of Rs. 193,500 per year. The cost of treatment increased with the severity of the disease. The cost of treatment led to impoverishment in 52.8% of families and imposed a substantial economic burden and consequences on the patients.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed1781    
    Printed20    
    Emailed0    
    PDF Downloaded99    
    Comments [Add]    

Recommend this journal